Clinical Trials Logo

Colorectal Neoplasms clinical trials

View clinical trials related to Colorectal Neoplasms.

Filter by:

NCT ID: NCT05869097 Completed - Clinical trials for Metastatic Colorectal Adenocarcinoma

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Start date: November 1, 2020
Phase:
Study type: Observational

This study is a retrospective study to compare the efficacy and safety between trifluridine/tipiracil (TAS-102) plus bevacizumab (BEV) with TAS-102 monotherapy in refractory metastatic colorectal cancer (mCRC) from November 2020 to October 2022 at the Hunan Cancer Hospital.

NCT ID: NCT05845294 Completed - Colorectal Cancer Clinical Trials

A Study of the Effect of Short-term Structured Psychological Care in Patients

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The study explored the effects of short-term structured psychological care on the level of postoperative psychological resilience, stigma, anxiety and depression in patients with colorectal cancer colostomy.

NCT ID: NCT05816902 Completed - Colorectal Cancer Clinical Trials

AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer

Start date: January 1, 2016
Phase:
Study type: Observational

Background: To assist clinicians with diagnosis and optimal treatment decision-making, we attempted to develop and validate an artificial intelligence prediction model for lung metastasis (LM) in colorectal cancer (CRC) patients. Method: The clinicopathological characteristics of 46037 CRC patients from the Surveillance, Epidemiology, and End Results (SEER) database and 2779 CRC patients from a multi-center external validation set were collected retrospectively. After feature selection by univariate and multivariate analyses, six machine learning (ML) models, including logistic regression, K-nearest neighbor, support vector machine, decision tree, random forest, and balanced random forest (BRF), were developed and validated for the LM prediction. The optimization model with best performance was compared to the clinical predictor. In addition, stratified LM patients by risk score were utilized for survival analysis.

NCT ID: NCT05810714 Completed - Clinical trials for Colorectal Carcinoma

Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in Appalachia

Start date: November 20, 2021
Phase: N/A
Study type: Interventional

This clinical trial compares audio brochures and video brochures to usual care for increasing colorectal cancer (CRC) screening among adults living in Appalachia. Adults living in rural Appalachia experience increased rates of CRC, possibly due to the unique barriers to screening this population faces, such as lower socioeconomic status, limited health literacy, and less access to healthcare. The fecal immunochemical test (FIT) is a common CRC screening technique which allows individuals to complete the test at home and mail the kit back. A limitation of the current process for FIT screening outreach is that the instruction materials are heavy in text and not appropriate for individuals with limited health literacy. The audio and video brochures used in this clinical trial are instruction materials that have been specially designed to be appropriate for individuals of all health literacy levels. Providing these audio and video brochures with the FIT kits may increase CRC screening among adults living in Appalachia, compared to usual care.

NCT ID: NCT05782608 Completed - Colorectal Cancer Clinical Trials

IV Ibuprofen vs Ketorolac in Post Operative Pain in Colorectal Cancer Surgeries in Obese Patient

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to assess the Efficacy of IV Ibuprofen and Ketorolac in the Management of Postoperative Pain in obese patients Following abdominal cancer surgery.

NCT ID: NCT05773248 Completed - Colorectal Cancer Clinical Trials

ERAS in Colorectal Surgery: Benefits of Late Adoption

Start date: March 13, 2023
Phase:
Study type: Observational [Patient Registry]

The aim of this single-center retrospective cohort study is to explore the effect of late adaptation of an ERAS protocol in a high-volume colorectal surgical unit. The primary endpoint is the surgical outcome measured by early postoperative complications, defined by the comprehensive complications index. Secondary endpoints include amongst others LOS (length of stay), cost analysis, short-term follow-up in the ERAS group.

NCT ID: NCT05756725 Completed - Clinical trials for Colorectal Cancer Screening

Improving Cancer Screening and Follow-up in Community Health Centers

Start date: July 25, 2023
Phase: N/A
Study type: Interventional

This is an implementation science study that examines implementation of a single intervention and the development of practice-level implementation strategies to facilitate implementation of the intervention.

NCT ID: NCT05744362 Completed - Colorectal Cancer Clinical Trials

Outcome of Transanal Specimen Extraction Surgery for Elderly Colorectal Cancer Patients

Start date: November 1, 2022
Phase:
Study type: Observational

Retrospective analysis of a cohort of elderly CRC patients (aged ≥ 65 years) underwent transanal-NOSES between August 2008 and February 2022 was constructed. Data were obtained from China NOSES Database (CNDB). The primary outcomes included time to first flatus, postoperative hospital stays, 30-day postoperative complication and hospital mortality. The secondary outcomes were overall survival (OS) and disease-free survival (DFS).

NCT ID: NCT05742438 Completed - Colorectal Cancer Clinical Trials

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

This is a prospective randomized controlled trial. Investigators aimed to compare the effect of three different anesthetic adjuvants (continuous infusion of lidocaine or dexmedetomidine, intrathecal morphine injection) on the biomarker for cancer recurrence and metastasis. Patients undergoing elective colorectal cancer surgery will be randomly allocated to three parallel arms and the biomarkers for cancer recurrence and metastasis, inflammation, and immune response will be compared. And we will compare the clinical outcomes in the three method.

NCT ID: NCT05741255 Completed - Clinical trials for Acceptance and Commitment Therapy, Mental Health, Cognitive Impairment,Colorectal Cancer

Effect of Acceptance and Commitment Therapy Based Interventions on Mental Health and Cognitive Impairment for Patients With Advanced Colorectal Cancer

Start date: January 5, 2022
Phase: N/A
Study type: Interventional

The present study aims to: Determine the effect of acceptance and commitment therapy-based interventions on mental health and cognitive impairment for patients with advanced colorectal cancer. Research Hypothesis: Cancer patients who receive acceptance and commitment therapy-based interventions will exhibit better mental health and lower cognitive impairments than those who didn't receive it.